Literature DB >> 17562681

Influence of the beta-lactam resistance phenotype on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media.

Asunción Fenoll1, Lorenzo Aguilar, Olga Robledo, María-José Giménez, David Tarragó, Juan-José Granizo, Mercedes Gimeno, Pilar Coronel.   

Abstract

OBJECTIVES: To study the influence of resistance phenotypes (based on sentinel antibiotics: penicillin and amoxicillin with/without clavulanate) on the cefuroxime versus cefditoren susceptibility of Streptococcus pneumoniae and Haemophilus influenzae recovered from children with acute otitis media.
METHODS: Middle ear isolates (193 S. pneumoniae and 114 H. influenzae) received in the Spanish Reference Laboratory (Instituto de Salud Carlos III) were tested. Antimicrobial susceptibility to penicillin, amoxicillin with/without clavulanate, cefuroxime and cefditoren was determined by agar dilution using Mueller-Hinton agar supplemented with 5% sheep blood for S. pneumoniae and Haemophilus Test Medium for H. influenzae. Strains were classified according to penicillin susceptibility (S. pneumoniae) or beta-lactamase production (H. influenzae).
RESULTS: The decrease in penicillin susceptibility of S. pneumoniae (from the susceptible to the resistant category) decreased amoxicillin and cefuroxime susceptibility rates from 100% to 34% and 0%, respectively. All pneumococcal strains were inhibited by 0.5 mg/L cefditoren, including those from penicillin-resistant serotypes 14, 23F, 6B and 9V with higher amoxicillin versus penicillin MICs. Susceptibility rates of beta-lactamase-positive H. influenzae strains were 93.8% and 85.4% to amoxicillin/clavulanate and cefuroxime, respectively. Resistance to amoxicillin/clavulanate (MIC>or=8/4 mg/L) was 12.1% (8 out of 66) and 6.3% (3 out of 48) in beta-lactamase-negative and -positive strains, respectively. All H. influenzae strains were inhibited by <or=0.06 mg/L cefditoren.
CONCLUSIONS: Susceptibility to sentinel beta-lactams cannot predict activity of other members of the group. The addition of clavulanic acid to amoxicillin does not guarantee 100% coverage of H. influenzae, regardless of beta-lactamase production.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17562681     DOI: 10.1093/jac/dkm209

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  10 in total

1.  influence of TEM-1 beta-lactamase on the pharmacodynamic activity of simulated total versus free-drug serum concentrations of cefditoren (400 milligrams) versus amoxicillin-clavulanic acid (2,000/125 milligrams) against Haemophilus influenzae strains exhibiting an N526K mutation in the ftsI gene.

Authors:  M Torrico; L Aguilar; N González; M J Giménez; O Echeverría; F Cafini; D Sevillano; L Alou; P Coronel; J Prieto
Journal:  Antimicrob Agents Chemother       Date:  2007-07-30       Impact factor: 5.191

2.  Evolution of clonal and susceptibility profiles of serotype 19A Streptococcus pneumoniae among invasive isolates from children in Spain, 1990 to 2008.

Authors:  David Tarragó; Lorenzo Aguilar; Raquel García; María-José Gimenez; Juan-José Granizo; Asunción Fenoll
Journal:  Antimicrob Agents Chemother       Date:  2011-02-22       Impact factor: 5.191

3.  Two cases of severe invasive infections in children caused by Streptococcus pneumoniae serotype 14--case report.

Authors:  H Hupková; I Urbancíková; K Bazárová; Z Szovenyová; V Fandáková; M Bukovský
Journal:  Folia Microbiol (Praha)       Date:  2010-02-07       Impact factor: 2.099

4.  Enhanced in vivo activity of cefditoren in pre-immunized mice against penicillin-resistant S. pneumoniae (serotypes 6B, 19F and 23F) in a sepsis model.

Authors:  Fabio Cafini; Jose Yuste; Maria-Jose Giménez; David Sevillano; Lorenzo Aguilar; Luis Alou; Elisa Ramos-Sevillano; Martha Torrico; Natalia González; Ernesto García; Pilar Coronel; Jose Prieto
Journal:  PLoS One       Date:  2010-08-10       Impact factor: 3.240

5.  Update on the clinical utility and optimal use of cefditoren.

Authors:  José Barberán; Lorenzo Aguilar; María-José Giménez
Journal:  Int J Gen Med       Date:  2012-05-21

6.  Increase in serotype 19A prevalence and amoxicillin non-susceptibility among paediatric Streptococcus pneumoniae isolates from middle ear fluid in a passive laboratory-based surveillance in Spain, 1997-2009.

Authors:  Asunción Fenoll; Lorenzo Aguilar; Maria-Dolores Vicioso; Maria-Jose Gimenez; Olga Robledo; Juan-Jose Granizo
Journal:  BMC Infect Dis       Date:  2011-09-12       Impact factor: 3.090

7.  A Comparison of Cefditoren Pivoxil 8-12 mg/kg/day and Cefditoren Pivoxil 16-20 mg/kg/day in Treatment of Children With Acute Presumed Bacterial Rhinosinusitis: A Prospective, Randomized, Investigator-Blinded, Parallel-Group Study.

Authors:  Orapan Poachanukoon; Auchara Tangsathapornpong; Sermkiat Tanuchit
Journal:  Clin Exp Otorhinolaryngol       Date:  2015-05-13       Impact factor: 3.372

Review 8.  Guidelines for the Antibiotic Use in Adults with Acute Upper Respiratory Tract Infections.

Authors:  Young Kyung Yoon; Chan Soon Park; Jae Wook Kim; Kyurin Hwang; Sei Young Lee; Tae Hoon Kim; Do Yang Park; Hyun Jun Kim; Dong Young Kim; Hyun Jong Lee; Hyun Young Shin; Yong Kyu You; Dong Ah Park; Shin Woo Kim
Journal:  Infect Chemother       Date:  2017-12

Review 9.  Revisiting cefditoren for the treatment of community-acquired infections caused by human-adapted respiratory pathogens in adults.

Authors:  María-José Giménez; Lorenzo Aguilar; Juan José Granizo
Journal:  Multidiscip Respir Med       Date:  2018-11-02

10.  High protein binding and cidal activity against penicillin-resistant S. pneumoniae: a cefditoren in vitro pharmacodynamic simulation.

Authors:  David Sevillano; Lorenzo Aguilar; Luis Alou; María-José Giménez; Natalia González; Martha Torrico; Fabio Cafini; Asunción Fenoll; Pilar Coronel; José Prieto
Journal:  PLoS One       Date:  2008-07-23       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.